Type 2 diabetes is associated with an increased risk for cardiovascular dis
ease. In recent years, prospective studies have indicated that, in addition
to conventional risk factors, glycaemic control of diabetes predicts cardi
ovascular disease in both middle-aged and elderly patients with Type 2 diab
etes. However, there are no consistent data from different studies to indic
ate that postprandial glucose is a better predictor for cardiovascular risk
than fasting glucose level. Although no clinical trials are available to s
how that improving glycaemic control prevents cardiovascular mortality and
morbidity, recent studies imply that hyperglycaemia in patients with Type 2
diabetes should be treated more intensively than recommended by current gu
idelines.